NAG
CRSP icon

Northstar Advisory Group’s CRISPR Therapeutics CRSP Stock Holding History

Northstar Advisory Group’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,495
Closed -$503K – 101
2021
Q3 		$503K Buy
+4,495
New +$503K 0.49% 34